P. Nash
发表论文 37 篇 · 总被引 426 次 · h-index 7
代表论文
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update (2024 · Annals of the Rheumatic Diseases · 被引 344)
- What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes? (2024 · Therapeutic Advances in Musculoskeletal Disease · 被引 22)
- Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study (2024 · RMD Open · 被引 11)
- Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials (2024 · Journal of Rheumatology · 被引 5)
- Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison (2024 · Rheumatology and Therapy · 被引 4)
- Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison (2024 · Rheumatology and Therapy · 被引 4)